Study: Treatment-resistant childhood leukemia tied to gene

01/12/2009 | Yahoo!

Dutch and German researchers found that children with a subtype of acute lymphoblastic leukemia who have the BCR-ABL1 fusion gene are more prone to relapse than patients without the gene. The finding suggests that carriers of the gene should get more intensive treatment with medicines already on the market "or with new, more-targeted drugs for which the biology of the BCR-ABL1-like subtype needs further study," the lead scientist said.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations